Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Director Paul B.

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) Director Paul B. Manning bought 200,000 shares of Verrica Pharmaceuticals stock in a transaction on Monday, July 24th. The stock was acquired at an average cost of $5.02 per share, for a total transaction of $1,004,000.00. Following the acquisition, the director now owns 7,851,128 shares in the […]

Related Keywords

United States , Paulb Manning , , Verrica Pharmaceuticals Company Profile , Institutional Trading Of Verrica Pharmaceuticals , Kovitz Investment Group Partners , Capital Management , Tower Research Capital , Verrica Pharmaceuticals Inc , Nasdaq , Verrica Pharmaceuticals Price Performance , News Ratings For Verrica Pharmaceuticals Daily , Verrica Pharmaceuticals , Get Free Report , Director Paul , Investment Group Partners , Research Capital , Jane Street Group , Pharmaceuticals Inc , Verrica Pharmaceuticals Daily , Nasdaq Vrca , Vrca , Medical , Insider Trading , Nsider Trades , Tocks ,